Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-01-23 1:34 pm Sale | 13G | RALLYBIO CORP COM RLYB | Tekla Capital Management LLC | 1,727,067 4.600% | -581,603 (-25.19%) | View |
| 2022-01-21 12:20 pm Purchase | 13G | RALLYBIO CORP COM RLYB | Tekla Capital Management LLC | 2,308,670 7.200% | 2,308,670 (New Position) | View |
| 2021-01-29 08:51 am Sale | 13G | Zyla Life Sciences ZCOR | Tekla Capital Management LLC | 0 0.000% | -656,921 (Position Closed) | View |
| 2020-01-24 08:03 am Purchase | 13G | Zyla Life Sciences ZCOR | Tekla Capital Management LLC | 656,921 7.000% | 656,921 (New Position) | View |
| 2020-01-24 08:01 am Sale | 13G | Oruka Therapeutics Inc. ORKA | Tekla Capital Management LLC | 36,068 2.300% | -775,159 (-95.55%) | View |